Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitegliknik.com
CategoryBioTech
Phone202-346-1100
Employees
Founded2007

Offices

Baltimore, USA
801 W. Baltimore Street
Suite 501A
Baltimore, MD, 21201
USA

People

President and CEO
Board Of Directors
Board Of Directors
Board Of Directors
Board Of Directors
Director
Scientist

Funding

TOTAL $48.4M
FUNDING TOTAL $48.4M
Series A, 1/2010
$2.89M
Partial Close, 9/2010
$2.4M
Venture Round, 1/2011
Joel B. Braunstein
$3.5M
Partial Close, 9/2011
$2.04M
Series B, 10/2012
Baxter International
$4.9M
Partial Close, 4/2013
$9.83M
Venture Round, 5/2013
$20M
Partial Close, 9/2013
$2.84M

Tags

Gliknik

Gliknik, Inc., a biopharmaceuticals company, develops therapies for patients with cancer and immune disorders. Its Immunomodulator Platform involves in off-the-shelf peptide drugs that increase CD4, CD8, and antibody immune responses against cancer; Stradomer Platform produces drugs designed to mimic the eficacy of pooled human intravenous immunoglobulin; and Stradobody Platform produces compounds that are similar to moncolonal antibodies for tumor cell killing. The company was founded in 2007 and is based in Baltimore, Maryland.

Recent Milestones

  • Dollar
    Gliknik received $2.84M in Partial Close funding. (9/3/13)
    Posted 9/15/13 at 10:00pm via sec.gov
  • Dollar
    Gliknik received $20M in Venture Round funding. (5/13/13)
    Posted 5/13/13 at 6:47pm via dowjones.com
  • Dollar
    Gliknik received $9.83M in Partial Close funding. (4/26/13)
    Posted 5/28/13 at 8:18pm via sec.gov
  • Dollar
    Gliknik received $4.9M in Series B funding. (10/8/12)
    Posted 10/8/12 at 6:22pm via finsmes.com
  • Dollar
    Gliknik received $2.04M in Partial Close funding. (9/6/11)
    Posted 9/29/13 at 9:25pm via sec.gov
  • Dollar
    Gliknik received $3.5M in Venture Round funding. (1/6/11)
    Posted 1/6/11 at 6:15pm via finsmes.com
  • Dollar
    Gliknik received $2.4M in Partial Close funding. (9/3/10)
    Posted 12/20/13 at 2:54am via sec.gov
  • Dollar
    Gliknik received $2.89M in Series A funding. (1/13/10)
    Posted 12/4/13 at 6:19am via sec.gov
  • Check
    Gliknik added David S. Block as President and CEO.
    Posted 1/6/11 at 6:15pm

Videos

Screenshots

Gliknik screenshot
Above: Homepage
Uploaded: 5/29/13

Sources

  1. SEC (sec.gov) [edit]
  2. SEC (sec.gov) [edit]
  3. Gliknik Raises $3.5M in Equity Financing (finsmes.com) [edit]
  4. SEC (sec.gov) [edit]
  5. Gliknik Raises $4.9M in Series B Funding (finsmes.com) [edit]
  6. SEC (sec.gov) [edit]
  7. Gliknik Increases Funding to $20M, Preps Autoimmune Disease Drug for Trials (pevc.dowjones.com) [edit]
  8. SEC (sec.gov) [edit]
Edit This Page
Last Edited 12/20/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy